IRIS
PATTI, Giuseppe Rocco Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.014
AS - Asia 3.626
EU - Europa 2.967
SA - Sud America 471
AF - Africa 51
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.942
SG - Singapore 1.336
IE - Irlanda 1.144
CN - Cina 1.015
RU - Federazione Russa 672
BR - Brasile 413
HK - Hong Kong 413
DE - Germania 409
UA - Ucraina 385
TR - Turchia 336
VN - Vietnam 290
IT - Italia 131
IN - India 89
FR - Francia 51
GB - Regno Unito 40
CA - Canada 37
BD - Bangladesh 33
JP - Giappone 33
SE - Svezia 25
MX - Messico 24
AR - Argentina 23
FI - Finlandia 20
IQ - Iraq 20
ZA - Sudafrica 18
BE - Belgio 17
PL - Polonia 16
NL - Olanda 12
EC - Ecuador 11
ES - Italia 10
VE - Venezuela 10
AT - Austria 8
HU - Ungheria 8
ID - Indonesia 7
JO - Giordania 7
MA - Marocco 7
PK - Pakistan 7
AU - Australia 6
LT - Lituania 6
EU - Europa 5
KE - Kenya 5
PY - Paraguay 5
SA - Arabia Saudita 5
TN - Tunisia 5
JM - Giamaica 4
NP - Nepal 4
PH - Filippine 4
TW - Taiwan 4
UY - Uruguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
EG - Egitto 3
MY - Malesia 3
TH - Thailandia 3
AL - Albania 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
KR - Corea 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HT - Haiti 1
IR - Iran 1
LY - Libia 1
MW - Malawi 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 14.142
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.490
Dublin 1.141
Chandler 821
San Jose 651
Singapore 599
Dallas 592
Ashburn 422
Santa Clara 422
Hong Kong 409
Izmir 317
Nanjing 312
The Dalles 247
Boardman 194
Lawrence 189
Princeton 189
Moscow 183
Wilmington 130
New York 108
Nanchang 104
Ho Chi Minh City 96
L'aquila 85
Hanoi 81
Beijing 62
Columbus 61
Council Bluffs 60
Los Angeles 58
Pune 54
Shenyang 53
Hebei 42
Tianjin 40
Jiaxing 31
San Mateo 30
São Paulo 30
Tokyo 30
Kunming 29
Norwalk 29
Changsha 27
Frankfurt am Main 24
Shanghai 23
Ann Arbor 20
Jinan 20
Munich 20
Brussels 17
Lanzhou 17
Montreal 15
Mountain View 15
Warsaw 14
Brooklyn 13
London 13
Rio de Janeiro 13
Zhengzhou 13
Atlanta 12
San Francisco 12
Des Moines 11
Haiphong 11
Helsinki 11
Changchun 10
Johannesburg 10
Mexico City 10
Ningbo 10
Brasília 9
Da Nang 9
Manchester 9
Phoenix 9
Belo Horizonte 8
Campinas 8
Chennai 8
Chicago 8
Denver 8
Istanbul 8
Porto Alegre 8
Stockholm 8
Can Tho 7
Curitiba 7
Orem 7
Toronto 7
Amman 6
Amsterdam 6
Baghdad 6
Boston 6
Buenos Aires 6
Dhaka 6
Lappeenranta 6
Milan 6
Rome 6
Vienna 6
Biên Hòa 5
Fremont 5
Hangzhou 5
Houston 5
New Delhi 5
Phủ Lý 5
Quito 5
Redwood City 5
Seattle 5
Ankara 4
Caracas 4
Erbil 4
Falkenstein 4
Go Vap 4
Totale 10.005
Salva come PNG Salva come JPEG
Nome #
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis 146
Author`s Reply 125
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 121
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 115
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 115
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis 112
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment. 111
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis 111
Cardiogenic Shock Following Acute Myocardial Infarction: What's New? 111
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 108
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 106
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 106
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 105
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 101
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: The prospective, multicentre observational PREvention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) 101
Left atrial and auricular thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 99
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 98
Early and long-term results of stenting of diffuse coronary artery disease 97
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery 96
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial 95
Have statins beneficial anti-inflammatory as well as lipid-lowering effects 95
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 95
Comparability of efficacy and safety results among phase III trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation 95
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 Studies. 93
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 92
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 92
Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question! 92
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation 91
Atorvastatin for reduction of myocardial damage during angioplasty trials 91
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 91
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly 90
Platelets GP-IIB-IIA receptor inhibitors in ischemic patients 88
Apoptosis in recent myocardial infarction 87
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 87
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 87
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 87
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 87
Improvement of myocardial ischemia by subclavian stent implantation in patients with internal mammary grafts: A case report and review of the literature 87
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 86
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 86
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry) 86
Are we ready for a gender-specific approach in interventional cardiology? 86
Myocardial infarction during pregnancy and postpartum: A review 86
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 85
Statin loading for acute coronary syndromes 85
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction 84
Clinical benefits of statin pretreatment in patients undergoing coronary revascularization 84
Comparison among patients ≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents 84
Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale 84
Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina 83
Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass 83
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 83
Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysis 83
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study 83
The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation 83
Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study 82
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 82
Patients with atrial fibrillation and coronary events: Are we any closer to coming out from the labyrinth of the various antithrombotic strategies? 82
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 81
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 81
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 81
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: An unusual case of myocardial rupture 81
Effects of atorvastatin on arterial endothelial function in coronary bypass surgery 80
Apoptosis and post-infarction left ventricular remodeling 80
Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis 80
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 80
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 80
Percutaneous coronary interventions and statin therapy 79
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 79
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations 78
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 78
Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease 78
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 78
Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention - Results from the ARMYDA-2 (Antiplatelet therapy for reduction of MYocardial Damage during Angioplasty) study 78
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 78
Untitled 77
Dexamethasone-eluting stents and plasma concentrations of adhesion molecules in patients with unstable coronary syndromes: Results of the historically controlled SESAME study 77
The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences 77
Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery 77
Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus 77
Prasugrel versus clopidogrel 77
Editorial: Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction 77
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention 77
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis - A pilot study with ACTH-Depot plus tropisetron 76
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 76
Key references: Basic fibrinolysis and thrombolysis selected references: 1987-1997 76
Atorvastatin pretreatment in early percutaneous coronary intervention 76
Prevention of myocardial damage during coronary intervention 76
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: A prospective single-center registry in high-risk patients 76
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 76
Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy 75
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention 75
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 75
Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study 75
Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy 75
Chapter "Chronobiology of the haemostatic system", for the book “Physiology and pharmacology of biological rhythms” (Editors P. H. Redfern e B. Lemmer) (Springer) 75
Combining Antiplatelet and Anticoagulant Therapies 75
Intradevice misalignment predicts residual leak in patients undergoing left atrial appendage closure 74
Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention 74
Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score 73
Totale 8.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021216 0 0 0 0 0 0 0 0 0 0 216 0
2021/2022509 1 0 5 5 15 3 9 61 68 5 84 253
2022/20232.682 218 87 46 211 196 239 0 159 1.387 11 78 50
2023/2024483 98 25 31 22 39 192 2 39 0 24 2 9
2024/20252.765 22 31 273 55 258 308 389 142 760 139 194 194
2025/20264.183 251 456 414 424 325 364 851 247 472 269 110 0
Totale 14.365